Photocil for Vitiligo

PreclinicalSmall molecule

Photocil for Vitiligo is one of 94 small molecule programs targeting Psoriasis Vulgaris. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Psoriasis VulgarisActive, not recruiting

Atopic DermatitisActive, not recruiting

VitiligoActive, not recruiting

Psoriasis VulgarisPreclinical

Active, not recruiting

Atopic DermatitisPreclinical

Active, not recruiting

VitiligoPreclinical

Active, not recruiting

Competition

Competitive Landscape

127 competitors in Atopic Dermatitis

#DrugCompanyPhaseTrials

Fludara

Sanofi

Phase 3

1 2

Cytosar

Teva

Phase 3

1 3

Adtralza

LEO Pharma

Phase 3

16 4

Amlitelimab

Sanofi

Phase 3

2 5

DUPIXENT

Regeneron

Phase 3

1 6

Certolizumab

Johnson & Johnson

Phase 3

1 7

Jaktinib

SSuzhou Zelgen Biopharmaceuticals Co.,Ltd

Phase 3

4 8

ICP-332

BBeijing InnoCare Pharma Tech Co., Ltd.

Phase 3

2 9

VC005

JJiangsu vcare pharmaceutical technology co., LTD

Phase 3

5 10

Tilrekimig

Pfizer

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Psoriasis Vulgaris1 trial

Photocil (Topical) for the Treatment of Psoriasis Vulgaris

Completed·AApplied Biology, Inc.·N/A·NCT01916629·12 enrolled

Atopic Dermatitis1 trial

Photocil (Topical) for the Treatment of Atopic Dermatitis

Completed·AApplied Biology, Inc.·N/A·NCT01992172·7 enrolled

Vitiligo1 trial

Photocil (Topical) for the Treatment of Vitiligo

Completed·AApplied Biology, Inc.·N/A·NCT01992185·15 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Photocil for Vitiligo. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Photocil for Vitiligo compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Photocil for Vitiligo. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Applied Biology, Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AApplied Biology, Inc.

Photocil for Vitiligo

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Psoriasis Vulgaris1 trial

Atopic Dermatitis1 trial

Vitiligo1 trial

References

Drug Info

Quick Facts

Related News